Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Catheter Ablation of Focal Atrial Tachycardia Using Remote Magnetic Navigation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comparison of the novel vasodilator uridine triphosphate and adenosine for the measurement of fractional flow reserve

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). In the absence of results from large multicenter, randomized trials, we performed a systematic review and meta-analysis of available studies comparing IC to IV abciximab in these patients.
OriginalsprogEngelsk
TidsskriftThe Journal of invasive cardiology
Vol/bind22
Udgave nummer6
Sider (fra-til)278-82
Antal sider5
StatusUdgivet - 1 jun. 2010

ID: 32174916